2008
DOI: 10.1016/j.bmc.2008.04.023
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of piperazine derivatives as 5-HT7 receptor antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
16
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 16 publications
1
16
0
Order By: Relevance
“…A few related arylsulfamides with a spacer to phenyl-piperazine were testified as active structure for 5-HT 7 antagonist. 20 Considering the importance of benzoxazine-6-sulfonamide, and in continuation of our research program to discover and develop novel biologically active compounds, [21][22][23][24] we have planned to synthesize a new series of compounds having benzoxazine-6-sulfonamide moiety and screened them for their antimicrobial activities. The antibacterial and antifungal activities of all the newly synthesized compounds were evaluated in vitro against one Gram-positive bacterium, three Gram-negative bacteria and one fungus.…”
mentioning
confidence: 99%
“…A few related arylsulfamides with a spacer to phenyl-piperazine were testified as active structure for 5-HT 7 antagonist. 20 Considering the importance of benzoxazine-6-sulfonamide, and in continuation of our research program to discover and develop novel biologically active compounds, [21][22][23][24] we have planned to synthesize a new series of compounds having benzoxazine-6-sulfonamide moiety and screened them for their antimicrobial activities. The antibacterial and antifungal activities of all the newly synthesized compounds were evaluated in vitro against one Gram-positive bacterium, three Gram-negative bacteria and one fungus.…”
mentioning
confidence: 99%
“…3 Piperazinyl linked ciprofloxacin dimers reported as potent antibacterial agents against resistant strains. 4 Sulfonamide and substituted sulfonamide derivatives are important category of pharmacophores that have a wide spectrum of biological and pharmacological applications such as antimalarial, 5 antimicrobial, 6 antibacterial, 7,8 anticancer, 9 antifungal, 10 antihelmintic, 10 antioxidant, 11 antiHIV, 12 antitumor, 12 antiplasmodial, 13 antineoplastic, 14 antiproliferative 15 activities and additionally known to act as 5-HT 6 , 5-HT 7 receptor antagonists, 16,17 A2B and CXCR3 antagonists, 18,19 11b-HSD, 20 histone deacetylase (HDAC) inhibitors, 21 b-secretase (BACE1) inhibitors 22 and dual PI3K/mTOR inhibitors. 23 In recent years, literature reveals that the research interest and applications of antioxidants have constantly gathered high importance to eradicate the oxidative stress in humans.…”
Section: Introductionmentioning
confidence: 99%
“…The reported pharmacophoric hypothesis suggested the minimal structural requirements for 5-HT 2A antagonism consisted of two aryl rings and a basic nitrogen. 13 Based on our previous work, 14 we designed arylsulfonamide derivatives 11-24 and 28 to possess the arylpiperazine moieties as well as a three carbon spacer. …”
Section: Introductionmentioning
confidence: 99%
“…N-(Cyclopropylmethyl)-3-(4-(4-fluorophenyl)piperazin-1-yl)propan-1-amine (10d). Yellow oil (71%): 1 H (CDCl 3 , 400 MHz) d 6.99-6.95 (m, 2H), 6.89-6.86 (m, 2H), 3.16 (t, J = 4.8 Hz, 4H), 2.79 (s, 4H), 2.74-2.68 (m, 4H), 2.62 (t, J = 4.8 Hz, 2H), 2.09-2.07 (m, 2H), 0.88 (s, 1H), 0.66 (q, J = 7.2 Hz, 2H), 0.32 (q, J = 5.2 Hz, 2H).5.2.4.General procedure for the preparation of N-(R 2 -methyl)-4-methoxy-N-(3-(4-(R 1 -phenyl)piperazin-1-yl)propyl)-Ar-sulfonamide(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24) For the further conversion to sulfonamides, sodium hydride (1 mmol, 2 equiv) was added to a suspension of N-(R 2 -methyl)-3-(4-(R 1 -phenyl)piperazin-1-yl)propan-1-amine 9 and 10 (0.5 mmol, 1 equiv) in DMF (5 mL). After stirring at 60°C for 30 min under nitrogen, Ar-sulfonylchloride (0.75 mmol, 1.5 equiv) in DMF (5 mL) was added.…”
mentioning
confidence: 99%